Andere Sprachen VITA 34 AG London S.E.

Aktien

A0BL84

DE000A0BL849

0NLV

Realtime-Estimate Tradegate Andere Börsenplätze 13:30:00 05.07.2024			% 5 Tage	% 1. Jan.
4.46 ^EUR	-64.60%		+186.35%	+186.35%

01.06.	VITA 34 AG meldet Ergebnis für das erste Quartal zum 31. März 2024	CI
30.04.	VITA 34 AG meldet Ergebnis für das Geschäftsjahr zum 31. Dezember 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

VITA 34 AG Reports Earnings Results for the First Quarter Ended March 31, 2024	01.06.
Vita 34 significantly increases earnings and operating cash flow in the first quarter	31.05.
Vita 34 returns to growth path in 2023	30.04.
VITA 34 AG Reports Earnings Results for the Full Year Ended December 31, 2023	30.04.
VITA 34 : Declaration of Conformity 2024	26.04.
AFR: Vita 34 AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]	25.04.
Vita 34 closes 2023 with significantly better results than expected based on preliminary figures	19.04.
Vita 34 publishes preliminary figures on the course of business in 2023	31.01.
Vita 34 downsizes Management Board until further notice	02.01.
DD: Vita 34 AG: AOC Health GmbH, Acquisition of shares as part of a capital increase	11.12.
DD: Vita 34 AG: Jakub Julian Baran, buy	11.12.
NVR: Vita 34 AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution	07.12.
Vita 34 AG: resolves on cash capital increase under exclusion of subscription rights in the amount of up to 10% of the share capital, commitments from investors	27.11.
Vita 34 increases revenue and earnings in Q3 2023 and further stabilizes business development	24.11.
VITA 34 AG Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	24.11.
AFR: Vita 34 AG: Preliminary announcement of the publication of quarterly reports and quarterly/interim statements	17.11.
Internal investigation by Vita 34 AG reveals irregularities related to a limited number of biological samples at one of its subsidiaries regarding compliance with medical law requirements	10.11.
Vita 34 AG: A subsidiary of Vita 34, FamiCordTx, will file a lawsuit against a US licensor	27.09.23
VITA 34 AG Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	31.08.23
Vita 34 stabilizes business development in the second quarter and noticeably improves earnings	31.08.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen VITA 34 AG London S.E.

Aktien

A0BL84

DE000A0BL849

0NLV

Andere Sprachen

Filter